| Sanofi-Aventis (Suisse) SA - VaxigripTetra, Suspension pour injection dans une seringue pré-remplie | | 66427 | | 01 | | VaxigripTetra | | Suspension pour injection dans une seringue pré-remplie | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 12.06.2018 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus souche A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-179A) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Texas/50/2012 (H3N2)-like: reassortant virus NYMC X-223A) 15 µg, haemagglutininum influenzae B (Virus souche B/Brisbane/60/2008) 15 µg, haemagglutininum influenzae B (Virus souche B/Massachusetts/2/2012) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, octoxinolum-9, neomycinum. | | Packungsbestandteile | | | | | | | | Active Agent | Dose |
|---|
| | 15µg / 0.5ml | | | 15µg / 0.5ml | | | 15µg / 0.5ml |
| | | | Inactive agents | Dose |
|---|
| Disodium Phosphate Dihydrate | | | | 15µg / 0.5ml | | Potassium Chloride | | | Potassium Dihydrogenophosphate | | | Sodium Chloride | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
